Effect injected long-acting epinephrine addition albuterol treatment acute asthma children additional effect subcutaneous long-acting epinephrine Sus-Phrine albuterol acute pediatric asthma eight-month period patients prospective trial patients pediatric emergency department Forty-three children ages years mean age years acute asthma Group Sus-Phrine ml kg albuterol aerosols appropriate Group albuterol aerosols significant difference extent improvement groups minutes hours clinical score peak flow respiratory rate Subcutaneous long-acting epinephrine additional benefit agonist nebulization children acute asthma 